
Cameron Carl Foster MD
Assistant Professor, Radiology, UC, Davis School of Medicine
Join to View Full Profile
2315 Stockton BlvdRoom 1893 Davis TowerSacramento, CA 95817
Phone+1 916-703-2273
Fax+1 916-703-2267
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Cameron Foster, MD is a board certified nuclear medicine physician in Sacramento, California. He is currently licensed to practice medicine in California. He is an Assistant Professor at UC.
Education & Training
- University of California Davis HealthInternship, Transitional Year, 2003 - 2004
- University of California, Davis, School of MedicineClass of 2003
Certifications & Licensure
- CA State Medical License 2004 - 2026
- American Board of Nuclear Medicine Nuclear Medicine
Publications & Presentations
PubMed
- 1 citationsA Case of Heavily Pretreated HER2+ Colorectal Liver Metastases Responsive to Hepatic Arterial Infusion Chemotherapy.Ryan J Beechinor, Mustafa F Abidalhassan, Deborah F Small, Huong K Hoang, Ramit Lamba
Clinical Colorectal Cancer. 2023-06-01 - 9 citationsPreclinical Evaluation ofGa- andLu-Labeled Integrin αβ-Targeting Radiotheranostic Peptides.Tanushree Ganguly, Nadine Bauer, Ryan A Davis, Cameron C Foster, Rebecca E Harris
Journal of Nuclear Medicine. 2023-04-01 - 13 citationsRadioembolization Dosimetry with Total-Body 90Y PET.Gustavo Coelho Alves Costa, Benjamin Spencer, Negar Omidvari, Cameron C. Foster, Michael Rusnak
Journal of Nuclear Medicine. 2021-11-18
Press Mentions
- Businesses Tied to Oklahoma Congressmen Enjoy Federal LoansJuly 7th, 2020
Grant Support
- A novel molecularly targeted theranostic approach via the alphavbeta6 integrin for the detection and treatment of metastatic cancersUNIVERSITY OF CALIFORNIA AT DAVIS2023–2028